WO2000059921A1 - Preparation of saturated phytosterols - Google Patents

Preparation of saturated phytosterols Download PDF

Info

Publication number
WO2000059921A1
WO2000059921A1 PCT/CA2000/000357 CA0000357W WO0059921A1 WO 2000059921 A1 WO2000059921 A1 WO 2000059921A1 CA 0000357 W CA0000357 W CA 0000357W WO 0059921 A1 WO0059921 A1 WO 0059921A1
Authority
WO
WIPO (PCT)
Prior art keywords
phytosterols
mixture
raw material
hydrogenation
solvent
Prior art date
Application number
PCT/CA2000/000357
Other languages
French (fr)
Inventor
Alfred Wong
Wilfred Nicholas Boguski
Original Assignee
B.C. Chemicals Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B.C. Chemicals Ltd. filed Critical B.C. Chemicals Ltd.
Priority to AU36509/00A priority Critical patent/AU3650900A/en
Publication of WO2000059921A1 publication Critical patent/WO2000059921A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B13/00Recovery of fats, fatty oils or fatty acids from waste materials
    • C11B13/005Recovery of fats, fatty oils or fatty acids from waste materials of residues of the fabrication of wood-cellulose (in particular tall-oil)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02WCLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
    • Y02W30/00Technologies for solid waste management
    • Y02W30/50Reuse, recycling or recovery technologies
    • Y02W30/74Recovery of fats, fatty oils, fatty acids or other fatty substances, e.g. lanolin or waxes

Definitions

  • the present invention relates to the preparation of saturated phytosterols and, more particularly, to a method of preparing an end product mixture of saturated phytosterols, at -least a substantial of the mixture consisting of saturated phytosterols, from a raw material mixture of phytosterols derived from tall oil, at least a substantial portion of the raw material mixture consisting of unsaturated phytosterols.
  • phytosterols One important source of phytosterols is tall oil, and there are known methods for isolating phytosterols and their saturated or hydrogenated (stanol) forms either from tall oil soap (sometimes referred to as soap skimmings) or from tall oil pitch.
  • ⁇ -sitosterol and campesterol When phytosterols are isolated from tall oil, a portion of the isolated mix (normally including ⁇ -sitosterol and campesterol) will typically include at least some hydrogenated forms of the sterols (viz. ⁇ -sitostanol and campestanol). However, given the higher efficacy of ⁇ -sitostanol compared to ⁇ -sitosterol, it is desirable that substanti.ally all ⁇ -sitosterols present in any such mix should be converted to ⁇ -sitostanols.
  • the conversion of a sterol to a stanol is, by definition, hydrogenation.
  • hydrogenation it is known to hydrogenate a phytosterol or a phytosterol mixture by mixing the phytosterol with a solvent in a reactor in the presence of an appropriate catalyst.
  • hydrogenation is mandated, relatively little attention has been paid to how hydrogenation may best be achieved, including which solvent may be best suited to the hydrogenation process.
  • the ability to do so can be impaired if the execution of the hydrogenation process introduces impurities or contaminants either as the result of phytosterol break down or otherwise. Impurities or contaminants that are carried with the saturated phytosterols may, at added cost, require removal. Likewise, to extend the lifetime of the hydrogenation solvent, any impurities or contaminants that are carried with the solvent may require removal before the solvent is recycled.
  • a further important factor that contributes to the overall cost of producing saturated phytosterols is the time that it takes to dry or sufficiently remove the presence of solvent from the end product.
  • saturated phytosterols are to be used in the preparation of food additives or dietary supplements, government regulations typically will permit the presence of only a very small amount of solvent residue (for example, 50 parts per million).
  • a primary object of the present invention is to provide a new and improved method for efficiently preparing a high purity end product mixture of saturated phytosterols from a raw mixture of phytosterols derived from tall oil - and one which converts a high percentage of unsaturated phytosterols present in the raw material mixture to corresponding saturated phytosterols.
  • a method for the preparation of an end product mixture of phytosterols, at least a substantial portion of the mixture consisting of saturated phytosterols, from a raw material mixture of phytosterols derived from tall oil, at least a substantial portion of the raw material mixture consisting of unsaturated phytosterols, such method comprising the steps of
  • the temperature is greater than 35 deg. C. (preferably about 40 deg. C. or higher) and the pressure is greater than standard pressure (preferably about 20 psi or higher).
  • Suitable catalysts include platinum dioxide and palladium. However, by reason of its lower cost, the latter is preferred.
  • the resulting end product mixture of saturated phytosterols may be used for various purposes including the manufacture of food additives or dietary supplements with a view to facilitating the reduction of serum cholesterol levels.
  • pressures when expressed as "psi" are pressures relative to standard pressure.
  • 20 psi as used above means 20 psi in excess of standard pressure.
  • Standard pressure is about 14.7 pounds per square inch absolute.
  • Solvents other than ethyl acetate may be used to prepare a mixture of saturated phytosterols from a mixture of unsaturated phytosterols derived from tall oil. Such other solvents include ethanol and isopropanol. However, ethyl acetate has been found to produce surprisingly unique results.
  • ethyl acetate With ethyl acetate, it is possible not only to achieve conversion ratios above 97% and approaching 99% or higher but, in so doing, to produce a resulting saturated phytosterol mixture that has particularly high purity. Moreover, it has been found that a saturated phytosterol mixture produced with ethyl acetate as the solvent can be filtered and dried (e.g. to less than 50 ppm solvent residue) substantially more efficiently than when produced with solvents such as ethanol or isopropanol.
  • the FIGURE is a representation of a gas chromatograph (GC) trace obtained upon hydrogenation of a raw material mixture of phytosterols as described below, in part serving to illustrate results that are achieved when (in accordance with the present invention) ethyl acetate is used as the hydrogenation solvent, and also serving to illustrate results that are achieved when (not in accordance with the present invention) ethanol or ispropanol is used as the hydrogenation solvent.
  • GC gas chromatograph
  • raw material phytosterol mixtures that are isolated from tall oil typically will include both unsaturated and saturated phytosterols.
  • Table 1 below indicates characteristics of raw material crystalline mixes that may be derived from softwood trees indigenous to northern British Columbia (including spruce, lodgepole pine and sub-alpine fir). TABLE 1
  • Phytosterols > 95% by weight ⁇ -sitosterol 55 - 60% by weight ⁇ -sitostanol 12 - 18% by weight campesterol 12 - 17% by weight campestanol 2 - 4% by weight other sterols ⁇ 3% by weight
  • Phytosterol mixtures as indicated in Table 1 may be used in the manufacture of cholesterol lowering agents without any hydrogenation step. However, hydrogenation is desirable because ⁇ -sitostanol is recognized as having an efficacy significantly higher and an absorption rate significantly lower than ⁇ -sitosterol.
  • Raw material mixtures as indicated in Table 1 are themselves considered useful to be used directly for the manufacture of food additives or dietary supplements that have serum cholesterol lowering properties.
  • hydrogenation is desirable because ⁇ -sitostanol is recognized as having particularly high efficacy and because ⁇ -sitosterol is the most plentiful unhydrogenated phytosterol.
  • the temperature used in accordance with the invention is greater than 35 deg. C, and preferably about 40 deg. C. or higher where the percent conversion is in the high 90% range.
  • Reduced drying time represents a significant advantage that ethyl acetate provides over solvents such as ethanol and isopropanol. However, it has also been found the use of ethyl acetate mitigates against impurities that tend to appear in the end product mixture when ethanol or isopropanol is used.
  • FIGURE is generally representative of GC traces that will be obtained upon hydrogenation of a raw material mixture like that indicated in Table 1. As shown, the trace includes three major peaks: Pea l Internal Standard (cholesterol)
  • Peak 4 to the right of peak 3 is representative of other sterols.
  • Peak 5 to the left of peak 1 represents undesirable impurities. Although there is a degree of uncertainty, it is thought to be generated by dehydroxylated forms of sterols (campestane and stigmastane).

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Steroid Compounds (AREA)

Abstract

An end product mixture substantially comprising saturated phytosterols is prepared from a raw material mixture of phytosterols derived from tall oil. At least a substantial portion of the raw material mixture consists of unsaturated phytosterols. The method includes the step of hydrogenating the raw material mixture in a solvent substantially comprising ethyl acetate while in the presence of a hydrogenation catalyst, then filtering and drying the hydrogenation product to separate the mixture of saturated phytosterols from the solvent and to leave an amount of solvent residue in the mixture that is not greater than a desired amount. Hydrogenation is carried out at a temperature greater than 35 deg. C., preferably 40 deg. C or higher, and at a pressure greater than standard pressure, preferably 20 psi or higher. The resulting mixture of saturated phytosterols may be used for various purposes including the manufacture of food additives or dietary supplements with a view to facilitating the reduction of serum cholesterol levels.

Description

PREPARATION OF SATURATED PHYTOSTEROLS
FIELD OF THE INVENTION
The present invention relates to the preparation of saturated phytosterols and, more particularly, to a method of preparing an end product mixture of saturated phytosterols, at -least a substantial of the mixture consisting of saturated phytosterols, from a raw material mixture of phytosterols derived from tall oil, at least a substantial portion of the raw material mixture consisting of unsaturated phytosterols.
BACKGROUND TO THE INVENTION
It has been known for many years that plant sterols or phytosterols can serve to effectively reduce serum cholesterol levels. In various studies, β-sitosterol and, even moreso, its hydrogenated form (β-sitostanol), has been recognized as particularly efficacious.
One important source of phytosterols is tall oil, and there are known methods for isolating phytosterols and their saturated or hydrogenated (stanol) forms either from tall oil soap (sometimes referred to as soap skimmings) or from tall oil pitch.
When phytosterols are isolated from tall oil, a portion of the isolated mix (normally including β-sitosterol and campesterol) will typically include at least some hydrogenated forms of the sterols (viz. β-sitostanol and campestanol). However, given the higher efficacy of β-sitostanol compared to β-sitosterol, it is desirable that substanti.ally all β-sitosterols present in any such mix should be converted to β-sitostanols.
The conversion of a sterol to a stanol is, by definition, hydrogenation. Generally, it is known to hydrogenate a phytosterol or a phytosterol mixture by mixing the phytosterol with a solvent in a reactor in the presence of an appropriate catalyst. However, while hydrogenation is mandated, relatively little attention has been paid to how hydrogenation may best be achieved, including which solvent may be best suited to the hydrogenation process.
From an economic or commercial point of view, it is highly desirable to effect the hydrogenation of a phytosterol or a phytosterol mix as quickly as possible. In this regard, it is recognized that one possible way to accelerate the hydrogenation process is to carry out the process at an elevated temperature or at an elevated temperature and pressure. However, if the temperature is excessive, then the phytosterols will degrade or break down.
Further, and again from an economic or commercial point of view, it is highly desirable to be able to produce high purity saturated phytosterols while recycling or reusing the hydrogenation solvent with many successive batches of raw material phytosterols.
However, the ability to do so can be impaired if the execution of the hydrogenation process introduces impurities or contaminants either as the result of phytosterol break down or otherwise. Impurities or contaminants that are carried with the saturated phytosterols may, at added cost, require removal. Likewise, to extend the lifetime of the hydrogenation solvent, any impurities or contaminants that are carried with the solvent may require removal before the solvent is recycled.
A further important factor that contributes to the overall cost of producing saturated phytosterols is the time that it takes to dry or sufficiently remove the presence of solvent from the end product. When saturated phytosterols are to be used in the preparation of food additives or dietary supplements, government regulations typically will permit the presence of only a very small amount of solvent residue (for example, 50 parts per million).
Accordingly, a primary object of the present invention is to provide a new and improved method for efficiently preparing a high purity end product mixture of saturated phytosterols from a raw mixture of phytosterols derived from tall oil - and one which converts a high percentage of unsaturated phytosterols present in the raw material mixture to corresponding saturated phytosterols. SUMMARY OF THE INVENTION
In accordance with a broad aspect of the present invention, there is provided a method for the preparation of an end product mixture of phytosterols, at least a substantial portion of the mixture consisting of saturated phytosterols, from a raw material mixture of phytosterols derived from tall oil, at least a substantial portion of the raw material mixture consisting of unsaturated phytosterols, such method comprising the steps of
(a) hydrogenating the raw material mixture in a solvent substantially comprising ethyl acetate while in the presence of a hydrogenation catalyst to produce a hydrogenation product comprising the end product mixture in the solvent; and,
(b) filtering and drying the hydrogenation product to separate the end product mixture from the solvent and to thereby leave an amount of solvent residue in the end product mixture that is not greater than a predetermined amount
During hydrogenation, the temperature is greater than 35 deg. C. (preferably about 40 deg. C. or higher) and the pressure is greater than standard pressure (preferably about 20 psi or higher). Suitable catalysts include platinum dioxide and palladium. However, by reason of its lower cost, the latter is preferred.
After filtering and drying to reduce the amount of solvent and solvent residue, the resulting end product mixture of saturated phytosterols may be used for various purposes including the manufacture of food additives or dietary supplements with a view to facilitating the reduction of serum cholesterol levels.
Herein, and in the claims, it is to be understood that pressures when expressed as "psi" are pressures relative to standard pressure. Thus, for example, 20 psi as used above means 20 psi in excess of standard pressure. Standard pressure is about 14.7 pounds per square inch absolute. Solvents other than ethyl acetate may be used to prepare a mixture of saturated phytosterols from a mixture of unsaturated phytosterols derived from tall oil. Such other solvents include ethanol and isopropanol. However, ethyl acetate has been found to produce surprisingly unique results. With ethyl acetate, it is possible not only to achieve conversion ratios above 97% and approaching 99% or higher but, in so doing, to produce a resulting saturated phytosterol mixture that has particularly high purity. Moreover, it has been found that a saturated phytosterol mixture produced with ethyl acetate as the solvent can be filtered and dried (e.g. to less than 50 ppm solvent residue) substantially more efficiently than when produced with solvents such as ethanol or isopropanol.
BRIEF DESCRIPTION OF THE DRAWINGS
The FIGURE is a representation of a gas chromatograph (GC) trace obtained upon hydrogenation of a raw material mixture of phytosterols as described below, in part serving to illustrate results that are achieved when (in accordance with the present invention) ethyl acetate is used as the hydrogenation solvent, and also serving to illustrate results that are achieved when (not in accordance with the present invention) ethanol or ispropanol is used as the hydrogenation solvent.
DETAB-JED DESCRIPTION
As noted above, raw material phytosterol mixtures that are isolated from tall oil typically will include both unsaturated and saturated phytosterols. In more detail, Table 1 below indicates characteristics of raw material crystalline mixes that may be derived from softwood trees indigenous to northern British Columbia (including spruce, lodgepole pine and sub-alpine fir). TABLE 1
Typical Values
Phytosterols: > 95% by weight β-sitosterol 55 - 60% by weight β-sitostanol 12 - 18% by weight campesterol 12 - 17% by weight campestanol 2 - 4% by weight other sterols < 3% by weight
Melting Point 132 - 140 deg. C.
Phytosterol mixtures as indicated in Table 1 may be used in the manufacture of cholesterol lowering agents without any hydrogenation step. However, hydrogenation is desirable because β-sitostanol is recognized as having an efficacy significantly higher and an absorption rate significantly lower than β-sitosterol.
Raw material mixtures as indicated in Table 1 are themselves considered useful to be used directly for the manufacture of food additives or dietary supplements that have serum cholesterol lowering properties. However, hydrogenation is desirable because β-sitostanol is recognized as having particularly high efficacy and because β-sitosterol is the most plentiful unhydrogenated phytosterol.
Several tests were conducted under various conditions of temperature and pressure utilizing raw material (RM) mixes like that indicated in Table 1. In each case, the raw material mixture was first mixed with ethyl acetate (ETAC), then introduced together with a hydrogenation catalyst (CAT) to a stirred reactor where hydrogenation took place under controlled conditions of temperature and pressure. The catalyst used was 5% palladium on a carbon support. Thereafter, the hydrogenation product (viz. the end product mixture of phytosterols in the solvent) was filtered, cooled, separated and dried by conventional means well known to those skilled in the art.
GC analysis was then used to analyze the end product mixture and to calculate the percentage of stanols present therein. Table 2 summarizes the test conditions and results.
TABLE 2
Test RM/SOL CAT/RM H2press, Temp. Run Time Conversion
(wt %) (wt %) (psi) (°C) (min.) (%)
2.01 8 10 20 20 120 50
2.02 8 10 20 30 120 73
2.03 8 10 20 40 120 98
2.04 8 10 20 50 120 99
2.05 8 10 40 50 120 99
2.06 8 10 40 65 120 99
2.07 8 10 65 65 120 99
2.08 8 6 75 100 120 97
2.09 8 6 75 100 120 97
2.10 8 6 75 100 120 98
2.11 8 9 75 100 120 97
2.12 8 10 75 100 120 99
2.13 15 10 75 100 120 99
2.14 15 10 75 100 240 100
2.15 8 10 75 100 120 98
In Table 2, the column headed "Conversion" is a calculation of 100% times the amount of saturated phytosterols present in the end product mixture divided by the sum of such amount and the amount of unsaturated phytosterols present in the end product mixtures. The amounts were determined in mg/g from the analysis of the GC traces.
From Table 2, it will be noted that there is a rapid decrease in percent conversion as the temperature of hydrogenation drops below 40 deg. C. For this reason, the temperature used in accordance with the invention is greater than 35 deg. C, and preferably about 40 deg. C. or higher where the percent conversion is in the high 90% range.
Further, although a relatively high percent conversion is shown at 40 deg. C and a hydrogen pressure of 20 psi, it is noteworthy that the percent conversion remains high at elevated temperatures and pressures. This indicates a substantial absence of phytosterol break down under such elevated conditions. Further, since conversion efficiency is approximately the same at 75 psi and 100 deg. C as it is at 20 psi and 40 deg. C, and since the conversions taking place may be accelerated at higher temperatures and pressures, it follows that comparable results should be achieved with run times less than 120 minutes as used in most of the tests.
Apart from the high conversion efficiencies that can be achieved while using ethyl acetate as the hydrogenation solvent, it has also been found that required drying times are significantly less than is required with other solvents such as ethanol and isopropanol. By way of example, a sample of raw material like that shown in Table 1 that was hydrogenated in ethyl acetate in the manner described above was dried for 2 hours at 105 deg. C under an absolute pressure of 25 mmhg. The result was fine white phytosterol crystals containing less than 50 ppm ethyl acetate. In comparison, the amount of solvent residue remaining in like samples that were hydrogenated in ethanol and in isopropanol exceeded ten times this amount after drying for twice as long.
Reduced drying time represents a significant advantage that ethyl acetate provides over solvents such as ethanol and isopropanol. However, it has also been found the use of ethyl acetate mitigates against impurities that tend to appear in the end product mixture when ethanol or isopropanol is used.
More particularly, reference is now made to the FIGURE. Except as noted below, the FIGURE is generally representative of GC traces that will be obtained upon hydrogenation of a raw material mixture like that indicated in Table 1. As shown, the trace includes three major peaks: Pea l Internal Standard (cholesterol)
Peak 2 Campestanol
Peak 3 β-sitostanol
Smaller peak 4 to the right of peak 3 is representative of other sterols. Peak 5 to the left of peak 1 represents undesirable impurities. Although there is a degree of uncertainty, it is thought to be generated by dehydroxylated forms of sterols (campestane and stigmastane).
In relation to the present invention, the most significant observation to be made with respect to the FIGURE is that peak 5 indicating the presence of impurities does not appear in the case of hydrogenation with ethyl acetate whereas it does appear in the cases of hydrogenation with either ethanol or isopropanol.

Claims

WE CLAIM:
1. A method for the preparation of an end product mixture of phytosterols, at least a substantial portion of said mixture consisting of saturated phytosterols, from a raw material mixture of phytosterols derived from tall oil, at least a substantial portion of said raw material mixture consisting of unsaturated phytosterols, said method comprising the steps of:
(a) hydrogenating said raw material mixture in a solvent substantially comprising ethyl acetate while in the presence of a hydrogenation catalyst to produce a hydrogenation product comprising said end product mixture in said solvent, said hydrogenating step being carried out at a temperature greater than 35 deg. C. and a pressure greater than standard pressure; and,
(b) filtering and drying said hydrogenation product to separate said end product mixture from said solvent and to thereby leave an amount of solvent residue in said end product mixture that is not greater than a desired amount.
2. A method as defined in claim 1 , wherein said hydrogenating step is carried out at a temperature of about 40 deg. C.
3. A method as defined in claim 1, wherein said hydrogenating step is carried out at a temperature of at least 40 deg. C.
4. A method as defined in claim 1, wherein said hydrogenating step is carried out at a temperature of about 100 deg. C.
5. A method as defined in claim 1, wherein said hydrogenating step is carried out at a temperature of at least 100 deg. C.
6. A method as defined in any one or more of claims 1 to 5, wherein said hydrogenating step is carried out at a pressure of about 20 psi.
7. A method as defined in any one or more of claims 1 to 5, wherein said hydrogenating step is carried out at a pressure of at least 20 psi.
8. A method as defined in any one or more of claims 1 to 5, wherein a substantial portion of said raw material mixture is β-sitosterol.
9. A method as defined in any one or more of claims 1 to 5, wherein a substantial portion of said raw material mixture is β-sitosterol, and wherein said hydrogenating step is carried out at a pressure of about 20 psi.
10. A method as defined in any one or more of claims 1 to 5, wherein a substantial portion of said raw material mixture is β-sitosterol, and wherein said hydrogenating step is carried out at a pressure of at least 20 psi.
11. A method as defined in any one or more of claims 1 to 10 wherein said hydrogenation catalyst is palladium.
12. A mixture of phytosterols prepared from tall oil in accordance with the method as defined in any one or more of the preceding claims.
PCT/CA2000/000357 1999-04-06 2000-04-05 Preparation of saturated phytosterols WO2000059921A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU36509/00A AU3650900A (en) 1999-04-06 2000-04-05 Preparation of saturated phytosterols

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA 2267929 CA2267929A1 (en) 1999-04-06 1999-04-06 Preparation of saturated phytosterols
CA2,267,929 1999-04-06

Publications (1)

Publication Number Publication Date
WO2000059921A1 true WO2000059921A1 (en) 2000-10-12

Family

ID=4163434

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2000/000357 WO2000059921A1 (en) 1999-04-06 2000-04-05 Preparation of saturated phytosterols

Country Status (3)

Country Link
AU (1) AU3650900A (en)
CA (1) CA2267929A1 (en)
WO (1) WO2000059921A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100440613B1 (en) * 2001-04-20 2004-08-16 주식회사 유엘바이오텍 Serum cholesterol lowering agent to use phytosterol and bio-flavonoid and methods for preparing them
WO2010010227A1 (en) * 2008-07-25 2010-01-28 Raisio Nutrition Ltd Improved hydrogenation process

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244887A (en) * 1992-02-14 1993-09-14 Straub Carl D Stanols to reduce cholesterol absorption from foods and methods of preparation and use thereof
WO1998038206A1 (en) * 1997-02-26 1998-09-03 Raisio Benecol Ltd. Process for the preparation of stanol esters
WO1999056558A1 (en) * 1998-05-06 1999-11-11 Raisio Benecol Oy Phytosterol compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244887A (en) * 1992-02-14 1993-09-14 Straub Carl D Stanols to reduce cholesterol absorption from foods and methods of preparation and use thereof
WO1998038206A1 (en) * 1997-02-26 1998-09-03 Raisio Benecol Ltd. Process for the preparation of stanol esters
WO1999056558A1 (en) * 1998-05-06 1999-11-11 Raisio Benecol Oy Phytosterol compositions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 70, no. 24, 16 June 1969, Columbus, Ohio, US; abstract no. 109125, ALLAIS, JEAN P. ET AL: "Preparation of pure.beta.- sitosterol by thin-layer chromatography on silver nitrate impregnated alumina" XP002145680 *
QUAL. PLANT. MATER. VEG. (1968), 16(1-4), 215-22 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100440613B1 (en) * 2001-04-20 2004-08-16 주식회사 유엘바이오텍 Serum cholesterol lowering agent to use phytosterol and bio-flavonoid and methods for preparing them
WO2010010227A1 (en) * 2008-07-25 2010-01-28 Raisio Nutrition Ltd Improved hydrogenation process

Also Published As

Publication number Publication date
CA2267929A1 (en) 2000-10-06
AU3650900A (en) 2000-10-23

Similar Documents

Publication Publication Date Title
FI65440C (en) FOERFARANDE FOER SEPARERING AV BETA-SITOSTEROL MED EN LAOG ALFA-SITOSTEROLHALT
US4298539A (en) Process for the isolation of β-sitosterol
US7244856B2 (en) Processes for recovering phytosterols via crystallization
US6855837B2 (en) Process for the preparation of stanol esters
DE102011050905A1 (en) Process for recovering proteins from a native composition
WO2000059921A1 (en) Preparation of saturated phytosterols
EP1173463B1 (en) Process for the purification of sterols from hydrocarbon extracts using evaporative fractionation
AU2002348729B2 (en) Process for crystallization of oryzanol from oryzanol enriched fraction derived from rice bran oil soap stock
US6673951B1 (en) Process for catalytically hydrogenating phytosterols
EP4034620A1 (en) Process for the production of sterols and/or tocopherols with recovery of by-products
EP3287014B1 (en) Process for producing a phytosterol-phystostanol composition
US7371876B2 (en) Process for the purification of sterols from hydrocarbon extracts using evaporative fractionation
DE1543769B2 (en) 7-Methoxy-flavan derivatives, process for their preparation and pharmaceuticals containing them
JP4645997B2 (en) Method for recovering unsaponifiable matter from tall oil pitch and method for producing sterols
EP4025676B1 (en) Production of an extract of phytosterols and stanols from tall oil pitch
RU2139293C1 (en) Sitosterol production method
DE1793595C3 (en) Intermediates for the preparation of 17-alpha-alkyl-, -alkenyl- or -alkynyl-13 beta-alkylgon-4- or -5 (10) -en-17 beta-ol-3-ones
WO2000004039A1 (en) Isolation and purification of sterols from neutrals fraction of tall oil pitch by single decantation precipitation
WO2000012533A1 (en) Isolation and purification of sterols from neutrals fraction of tall oil pitch by direct crystallization, dual phase
WO2000034305A1 (en) Isolation and purification of sterols from neutrals fraction of tall oil pitch by dual decantation crystallization
WO2000009535A1 (en) Isolation and purification of sterols from neutrals fraction of tall oil pitch by direct crystallization, single phase
WO2010010227A1 (en) Improved hydrogenation process
EP1389622A2 (en) Process for the purification of sterols from hydrocarborn extracts using evaporative fractionation
WO2000004038A1 (en) Isolation and purification of sterols from neutrals fraction of tall oil pitch by direct precipitation
JPH0686477B2 (en) Process for the preparation of Z and E stereoisomeric mixtures of pharmacologically active synthetic gagarsterone

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP